Cigna Corporation (NYSE:CI) VP Mary T. Hoeltzel sold 525 shares of the company’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $177.59, for a total transaction of $93,234.75. Following the transaction, the vice president now directly owns 1,924 shares of the company’s stock, valued at $341,683.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of Cigna Corporation (NYSE:CI) traded down 0.56% during trading on Friday, hitting $174.38. 1,174,009 shares of the company’s stock were exchanged. The stock has a market cap of $43.91 billion, a P/E ratio of 20.12 and a beta of 0.46. The firm has a 50-day moving average price of $172.22 and a 200-day moving average price of $159.17. Cigna Corporation has a one year low of $115.03 and a one year high of $178.57.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the consensus estimate of $2.48 by $0.43. Cigna Corporation had a net margin of 7.46% and a return on equity of 17.40%. The business had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. During the same quarter in the previous year, the business posted $1.98 EPS. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Equities research analysts expect that Cigna Corporation will post $10.02 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Insider Selling: Cigna Corporation (CI) VP Sells 525 Shares of Stock” was first posted by American Banking News and is the property of of American Banking News. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/08/11/insider-selling-cigna-corporation-ci-vp-sells-525-shares-of-stock.html.

Several equities analysts have recently commented on CI shares. Zacks Investment Research raised shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $175.00 price objective for the company in a research note on Tuesday, April 25th. Credit Suisse Group started coverage on shares of Cigna Corporation in a research note on Monday, June 12th. They set an “outperform” rating and a $185.00 price objective for the company. Jefferies Group LLC reaffirmed a “buy” rating and set a $183.00 price objective (up from $178.00) on shares of Cigna Corporation in a research note on Friday, May 5th. Stifel Nicolaus upped their price objective on shares of Cigna Corporation from $170.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, May 5th. Finally, Oppenheimer Holdings, Inc. upped their price objective on shares of Cigna Corporation from $174.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday, June 15th. Three equities research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $180.06.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. raised its position in Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock valued at $2,488,489,000 after buying an additional 16,289,943 shares during the period. JPMorgan Chase & Co. raised its position in Cigna Corporation by 40.8% in the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after buying an additional 1,184,632 shares during the period. Waddell & Reed Financial Inc. raised its position in Cigna Corporation by 125.8% in the first quarter. Waddell & Reed Financial Inc. now owns 1,749,647 shares of the health services provider’s stock valued at $256,306,000 after buying an additional 974,747 shares during the period. Wellington Management Group LLP raised its position in Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock valued at $1,577,075,000 after buying an additional 913,991 shares during the period. Finally, Thrivent Financial For Lutherans raised its position in Cigna Corporation by 7,868.4% in the first quarter. Thrivent Financial For Lutherans now owns 708,390 shares of the health services provider’s stock valued at $103,772,000 after buying an additional 699,500 shares during the period. Hedge funds and other institutional investors own 86.91% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.